drugset
Drugs / Anti-hypertensive medication titrated to a BP goal of <140/90 mmHg
last change 11 days ago re-read 9 days ago

Anti-hypertensive medication titrated to a BP goal of <140/90 mmHg

also known as nifedipine extended release
Developed for
hypertension, pregnancy-induced
Investigated by
Brown University · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) · The George Washington University Biostatistics Center · University of Alabama at Birmingham · University of Utah

Trials 1

today NCT07746271 · Ph 3
2027202820292030
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT07746271 Sep 2026 → Dec 2029 expected hypertension, pregnancy-induced The George Washington University Biostatistics Center Not yet recruiting No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Anti-hypertensive medication titrated to a BP goal of <140/90 mmHg ClinicalTrials.gov intervention name — accepted as the source's own label NCT07746271 ↗
Known as nifedipine extended release “Participants randomized to intervention will be initiated on labetalol or nifedipine extended release (ER).” NCT07746271 ↗